DCTH Delcath Systems, Inc. - Common Stock
$16,93
Prezzo · Ago 18, 2026
Fondamentali al Ago 6, 2026
Intervallo 52 sett.
$8–$17
95% of range
Rating Analisti
BUY
12 analysts
Prezzo Obiettivo
$24
+42% upside
P/E (TTM)
241.9
ROE
2.5%
Margine di Profitto Netto
3.2%
Informazioni su Delcath Systems, Inc. - Common Stock Panoramica della società da Wikipedia
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Leggi di più
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
DCTH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$16.93
Capitalizzazione di Mercato
$587M
P/E (TTM)
241.9
EPS (TTM)
$0.07
Ricavi (TTM)
$85M
Rendimento div.
—
ROE
2.5%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$8 – $17
DCTH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$85M
2016-12-31
→
2025-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
Flusso di cassa libero
$21M
2018-12-31
→
2025-12-31
Margini
3.2%
2022-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
DCTH
Mediana dei peer
P/E (TTM)
241.9
32.9
P/S (TTM)
6.9
4.6
P/B
5.3
3.5
Price / FCF (Prezzo / FCF)
28.0
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
DCTH
Mediana dei peer
Gross Margin (Margine lordo)
86.2%
66.5%
Operating Margin (Margine Operativo)
0.77%
—
Net Profit Margin (Margine di Profitto Netto)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
DCTH
Mediana dei peer
Current Ratio (Rapporto corrente)
10.9
4.8
Quick Ratio
5.0
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
DCTH
Mediana dei peer
Revenue YoY (Ricavi YoY)
129.1%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
215.3%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
DCTH
Mediana dei peer
DCTH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
12 analisti
- Acquisto forte 3 25,0%
- Compra 8 66,7%
- Mantieni 1 8,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
5 analisti · 2026-08-18
Mediana
$22.00
Media
$24.00
← Sotto tutti i target
$16.93
Basso
$21.00
Alto
$32.00
Target mediano
$22.00
+29,9%
Target medio
$24.00
+41,8%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.05%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.07 | $-0.09 | 0.16% |
| 31 Marzo 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 Dicembre 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 Settembre 2025 | $0.02 | $0.02 | -0.00% |
| 30 Giugno 2025 | $0.07 | $0.03 | 0.04% |
| 31 Marzo 2025 | $0.03 | $0.02 | 0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Flusso di cassa 12
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Redditività 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Tassi di Crescita 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Stato Patrimoniale 23
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Redditività 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $85M | $37M | $2M | $3M | $4M |
| Margine Lordo % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Margine Operativo % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Utile netto | $3M | $-26M | $-48M | $-37M | $-26M |
| EPS Diluito | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $21M | $-19M | $-31M | $-25M | $-23M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 140 filer · $188.2M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 27 (0 vs trimestre precedente) | 17 (-3 vs trimestre precedente) | 40 (+6 vs trimestre precedente) | 30 (-7 vs trimestre precedente) | +1.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41.551.898 | 3.300.389 | 22,08% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.375.500 | 1.221.247 | 8,17% | Azioni |
| VANGUARD GROUP INC | $14.879.573 | 1.473.225 | 7,91% | Azioni |
| Propel Bio Management, LLC | $10.971.681 | 871.460 | 5,83% | Azioni |
| STATE STREET CORP | $8.552.135 | 679.280 | 4,55% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $7.923.535 | 629.139 | 4,21% | Azioni |
| ALGERT GLOBAL LLC | $7.311.114 | 580.708 | 3,89% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.130.611 | 566.371 | 3,79% | Azioni |
| Divisadero Street Capital Management, LP | $6.292.432 | 499.796 | 3,34% | Azioni |
| ExodusPoint Capital Management, LP | $4.530.940 | 359.884 | 2,41% | Azioni |
| Private Wealth Advisors, LLC | $3.913.765 | 310.863 | 2,08% | Azioni |
| Simplify Asset Management Inc. | $3.333.454 | 264.770 | 1,77% | Azioni |
| BlackRock, Inc. | $3.180.738 | 252.640 | 1,69% | Azioni |
| ADAR1 Capital Management, LLC | $2.825.007 | 224.385 | 1,50% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $2.570.450 | 204.166 | 1,37% | Azioni |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.570.160 | 204.143 | 1,37% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.435.510 | 193.448 | 1,29% | Azioni |
| Ikarian Capital, LLC | $2.337.548 | 185.667 | 1,24% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $2.290.159 | 181.903 | 1,22% | Azioni |
| CIBC WORLD MARKET INC. | $2.054.789 | 163.208 | 1,09% | Azioni |
| Caption Management, LLC | $1.894.795 | 150.500 | 1,01% | Opzione Put |
| GOLDMAN SACHS GROUP INC | $1.885.353 | 149.750 | 1,00% | Azioni |
| Lane Generational LLC | $1.884.257 | 149.663 | 1,00% | Azioni |
| HSBC HOLDINGS PLC | $1.705.848 | 135.600 | 0,91% | Azioni |
| Man Group plc | $1.617.752 | 128.495 | 0,86% | Azioni |
| Cubist Systematic Strategies, LLC | $1.562.514 | 145.350 | 0,83% | Azioni |
| Diametric Capital, LP | $1.546.568 | 122.841 | 0,82% | Azioni |
| MORGAN STANLEY | $1.366.506 | 108.539 | 0,73% | Azioni |
| BARCLAYS PLC | $1.354.243 | 107.565 | 0,72% | Azioni |
| Caption Management, LLC | $1.259.000 | 100.000 | 0,67% | Opzione Call |
| Capital Advisors Wealth Management, LLC | $1.170.870 | 93.000 | 0,62% | Azioni |
| Jefferies Financial Group Inc. | $1.057.308 | 83.980 | 0,56% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.050.824 | 83.465 | 0,56% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.022.308 | 81.200 | 0,54% | Opzione Call |
| Stonepine Capital Management, LLC | $1.000.000 | 100.000 | 0,53% | Opzione Call |
| Caption Management, LLC | $978.243 | 77.700 | 0,52% | Azioni |
| FOX RUN MANAGEMENT, L.L.C. | $776.526 | 61.678 | 0,41% | Azioni |
| Quantbot Technologies LP | $749.860 | 59.560 | 0,40% | Azioni |
| D. E. Shaw & Co., Inc. | $728.885 | 57.894 | 0,39% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $725.864 | 57.654 | 0,39% | Azioni |
| Pale Fire Capital SE | $504.670 | 40.085 | 0,27% | Azioni |
| BANK OF AMERICA CORP /DE/ | $493.931 | 39.232 | 0,26% | Azioni |
| WOLVERINE TRADING, LLC | $479.600 | 44.000 | 0,25% | Opzione Call |
| RHUMBLINE ADVISERS | $458.822 | 36.444 | 0,24% | Azioni |
| ALPS ADVISORS INC | $441.154 | 35.040 | 0,23% | Azioni |
| EntryPoint Capital, LLC | $437.641 | 34.761 | 0,23% | Azioni |
| SEI INVESTMENTS CO | $394.936 | 31.369 | 0,21% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $378.380 | 30.054 | 0,20% | Azioni |
| Balyasny Asset Management L.P. | $358.412 | 28.468 | 0,19% | Azioni |
| Leonteq Securities AG | $348.730 | 27.699 | 0,19% | Azioni |
| CITADEL ADVISORS LLC | $334.894 | 26.600 | 0,18% | Opzione Call |
| BOOTHBAY FUND MANAGEMENT, LLC | $319.484 | 25.376 | 0,17% | Azioni |
| Xcelsior Advisor Partners LLC | $318.527 | 25.300 | 0,17% | Azioni |
| Palisades Investment Partners, LLC | $293.007 | 23.273 | 0,16% | Azioni |
| WOLVERINE TRADING, LLC | $269.666 | 24.740 | 0,14% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $239.424 | 25.800 | 0,13% | Azioni |
| MetLife Investment Management, LLC | $235.043 | 18.669 | 0,12% | Azioni |
| Bank of New York Mellon Corp | $234.942 | 18.661 | 0,12% | Azioni |
| WealthPlan Investment Management, LLC | $219.607 | 17.443 | 0,12% | Azioni |
| NOMURA HOLDINGS INC | $210.530 | 16.722 | 0,11% | Azioni |
| WOLVERINE TRADING, LLC | $209.280 | 19.200 | 0,11% | Opzione Put |
| CITADEL ADVISORS LLC | $202.699 | 16.100 | 0,11% | Opzione Put |
| CITADEL ADVISORS LLC | $189.391 | 15.043 | 0,10% | Azioni |
| SkyOak Wealth, LLC | $188.850 | 15.000 | 0,10% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188.850 | 15.000 | 0,10% | Opzione Put |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166.729 | 13.243 | 0,09% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $151.609 | 12.042 | 0,08% | Azioni |
| LANARK FINANCIAL, INC. | $150.500 | 11.954 | 0,08% | Azioni |
| CITIGROUP INC | $146.485 | 11.635 | 0,08% | Azioni |
| Invesco Ltd. | $143.790 | 11.421 | 0,08% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $140.744 | 11.179 | 0,07% | Azioni |
| Nuveen, LLC | $138.754 | 11.021 | 0,07% | Azioni |
| Vanguard Global Advisers, LLC | $133.869 | 10.633 | 0,07% | Azioni |
| Schonfeld Strategic Advisors LLC | $131.136 | 10.416 | 0,07% | Azioni |
| LPL Financial LLC | $128.859 | 10.235 | 0,07% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $126.580 | 10.054 | 0,07% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $110.729 | 8.795 | 0,06% | Azioni |
| SHERBROOKE PARK ADVISERS LLC | $109.918 | 10.883 | 0,06% | Azioni |
| Hunting Hill Global Capital, LLC | $104.716 | 11.284 | 0,06% | Azioni |
| MARSHALL WACE, LLP | $84.177 | 6.686 | 0,04% | Azioni |
| FMR LLC | $69.144 | 5.492 | 0,04% | Azioni |
| Private Wealth Advisors, LLC | $62.950 | 5.000 | 0,03% | Opzione Call |
| NEW YORK STATE COMMON RETIREMENT FUND | $60.432 | 4.800 | 0,03% | Azioni |
| OSAIC HOLDINGS, INC. | $60.254 | 4.786 | 0,03% | Azioni |
| Point72 (DIFC) Ltd | $53.931 | 5.017 | 0,03% | Azioni |
| NORTHERN TRUST CORP | $53.797 | 4.273 | 0,03% | Azioni |
| Persistent Asset Partners Ltd | $52.954 | 4.206 | 0,03% | Azioni |
| Arax Advisory Partners | $51.884 | 4.121 | 0,03% | Azioni |
| IFP Advisors, Inc | $51.657 | 4.103 | 0,03% | Azioni |
| Integrated Wealth Concepts LLC | $48.145 | 3.824 | 0,03% | Azioni |
| Ameritas Investment Partners, Inc. | $38.714 | 3.075 | 0,02% | Azioni |
| Legal & General Group Plc | $34.534 | 2.743 | 0,02% | Azioni |
| CWM, LLC | $29.343 | 3.162 | 0,02% | Azioni |
| Creative Planning | $17.777 | 1.412 | 0,01% | Azioni |
| Tripletail Wealth Management, LLC | $16.632 | 1.260 | 0,01% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.950 | 1.611 | 0,01% | Azioni |
| AlphaQuest LLC | $14.473 | 1.433 | 0,01% | Azioni |
| Tower Research Capital LLC (TRC) | $13.711 | 1.089 | 0,01% | Azioni |
| Activest Wealth Management | $12.590 | 1.000 | 0,01% | Azioni |
| Geneos Wealth Management Inc. | $11.621 | 923 | 0,01% | Azioni |
Insider aziendali 46 insider · 11 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 08 Maggio 2020 C | 25.021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 08 Maggio 2020 C | 12.851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 Novembre 2007 A | 3.375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 Ottobre 2023 P | 41.526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 Maggio 2007 P | 160.375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 Dicembre 2023 P | 100.000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 Novembre 2023 P | 30.000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 Novembre 2023 P | 40.000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 Giugno 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 Giugno 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 01 Settembre 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Direttore | 21 Agosto 2023 P | 10.550 | 0 | 0 | $0 |
| Aharon Gil | Direttore | 12 Giugno 2023 A | 404.000 | 0 | 0 | $0 |
| Steven A J Salamon | Direttore | 12 Giugno 2023 A | 440.100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Direttore | 12 Giugno 2023 A | 9.309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Direttore | 19 Aprile 2022 P | 433.100 | 0 | 0 | $0 |
| Marco Taglietti | Direttore | 08 Maggio 2020 C | 6.000 | 0 | 0 | $0 |
| William Dodge Rueckert | Direttore | 08 Maggio 2020 C | 6.014 | 0 | 0 | $0 |
| Simon Pedder | Direttore | 01 Febbraio 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Direttore | 23 Luglio 2015 P | 205.299 | 0 | 0 | $0 |
| Harold S Koplewicz | Direttore | 10 Giugno 2015 A | 45.052 | 0 | 0 | $0 |
| Dennis Langer | Direttore | 10 Giugno 2015 A | 20.000 | 0 | 0 | $0 |
| Jonathan Lewis | Direttore | 30 Giugno 2008 A | 10.000 | 0 | 0 | $0 |
| Mark Corigliano | Direttore | 16 Aprile 2007 M | 198.176 | 0 | 0 | $0 |
| Daniel Isdaner | Direttore | 16 Aprile 2007 M | 253.668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 Maggio 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 02 Marzo 2026 P | 342.034 | 2 | 0 | $198.447 |
| Laura Brege | — | 07 Luglio 2014 A | 11.678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 07 Luglio 2014 A | 11.678 | 0 | 0 | $0 |
| Gabriel Leung | — | 07 Luglio 2014 A | 21.485 | 0 | 0 | $0 |
| Douglas G Watson | — | 07 Luglio 2014 A | 136.664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 Novembre 2013 A | 54.000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 Novembre 2013 A | 15.000 | 0 | 0 | $0 |
| William M Appling | — | 15 Luglio 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 Marzo 2013 A | 159.000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 Marzo 2013 A | 17.000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 Marzo 2013 A | 162.000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 Marzo 2013 A | 80.944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 Giugno 2012 A | 69.534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 Marzo 2011 A | 47.706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 01 Dicembre 2010 A | 8.507 | 0 | 0 | $0 |
| Richard Taney | — | 10 Dicembre 2009 A | 211.485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 Ottobre 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 Gennaio 2007 X | 775.360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 Ottobre 2006 M | 180.007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 Novembre 2004 J | 892.649 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 17 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 depositi | 10 Febbraio 2026 | 9,90% | Modifica | — | SEC |
| Persona segnalante non divulgata | 16 Dicembre 2022 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 27 Luglio 2022 | — | Deposito iniziale | — | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 depositi | 02 Agosto 2010 | — | Deposito iniziale | — | SEC |
| Robert Ladd | 18 Ottobre 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 28 Luglio 2006 | — | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| Persona segnalante non divulgata | 11 Luglio 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 14 Giugno 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 08 Giugno 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 24 Maggio 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 28 Aprile 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 10 Gennaio 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 06 Gennaio 2006 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 14 Dicembre 2005 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata | 10 Novembre 2005 | — | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 22 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35.814 NS | 31 Maggio 2026 | N-PORT |
| IWC · iShares Trust | 0,10% | 97.850 SH | 08 Agosto 2026 | Giornaliero |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35.321 NS | 31 Maggio 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 227.534 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 21.358 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,01% | 741.852 SH | 08 Agosto 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.388 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 165.177 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 13.080 NS | 30 Aprile 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22.609 NS | 31 Maggio 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.420 NS | 31 Maggio 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.111 NS | 31 Maggio 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 38.572 SH | 08 Agosto 2026 | Giornaliero |
| URTY · ProShares Trust | 0,00% | 1.122 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.638 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19.222 NS | 30 Aprile 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 43.750 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 304.809 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 889.410 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.438 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.475 SH | 08 Agosto 2026 | Giornaliero |